NeutrArt
Set, Administration, Intravascular
Asset Medikal Tasarim AS.
The following data is part of a premarket notification filed by Asset Medikal Tasarim As. with the FDA for Neutrart.
Pre-market Notification Details
| Device ID | K221481 |
| 510k Number | K221481 |
| Device Name: | NeutrArt |
| Classification | Set, Administration, Intravascular |
| Applicant | Asset Medikal Tasarim AS. Ikitelli OSB Mahallesi, 17. Cadde, No: 17, Basaksehir Istanbul, TR 34490 |
| Contact | Ebru Sirali |
| Correspondent | Raymond Kelly Licensale Inc 3422 Leonardo Lane New Smyrna Beach, FL 32168 |
| Product Code | FPA |
| CFR Regulation Number | 880.5440 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Traditional |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 2022-05-23 |
| Decision Date | 2022-09-23 |
Trademark Results [NeutrArt]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 NEUTRART 98094162 not registered Live/Pending |
Asset Medical International, Inc. 2023-07-20 |
 NEUTRART 79310867 not registered Live/Pending |
ASSET MEDIKAL TASARIM SANAYI VE TICARETANONIM SIRKETI 2021-01-26 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.